Stocktoria
Septerna, Inc. SEPN
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2024-10-25
Septerna, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Operating margin | -148.6% | -7518.4% | 1374.2% |
| Net margin | -106.4% | -6678.9% | 2768.2% |
| FCF margin | 238.7% | -6471.9% | -27550.3% |
| Return on assets | -8.2% | -15.7% | 3.2% |
| Return on equity | -12.8% | -17.1% | -10.9% |
| Current ratio | 4.73 | 27.77 | 16.30 |
| Revenue growth | 4174.5% | 611.9% | — |
Source: SEC EDGAR filings · CIK 0001984086 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.